Has Dhruv Rajpurohit, DO received payments from drug or device companies?

Yes. Drug and device makers reported $10,296 in general payments to Dhruv Rajpurohit, DO across 173 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dhruv Rajpurohit, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dhruv Rajpurohit, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dhruv Rajpurohit, DO

Interventional Cardiology · Abilene, TXNPI 1740714534

Payments from drug & device makers

$10,296in general payments, 2019–2025

Across 173 payments — averaging $59.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$4K
Abiomed$1K
Medtronic$1K
Bard Peripheral Vascular, Inc.$880
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$475
Terumo Medical Corporation$379
plus $2K from 19 others

What the payments were for

Travel & lodging$2,88228%
Food & beverage$6,18160%
Education$1,21812%
Entertainment$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	39	$3,914
Abiomed	62	$1,242
Medtronic(2 entities)	10	$1,155
Bard Peripheral Vascular, Inc.	8	$880
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	13	$475
Terumo Medical Corporation	5	$379
Amgen	3	$348
E.r. Squibb & Sons, L.L.C.	2	$249
Shockwave Medical, Inc	3	$212
Penumbra, Inc.	2	$182
Philips North America LLC	2	$180
Sanofi	1	$150
Angiodynamics, Inc.	2	$146
Boston Scientific	2	$125
AbbVie	1	$107
Opsens Inc.	2	$91
Chiesi USA, Inc.	2	$89
Cordis US CORP.	2	$76
Novartis	4	$76
Edwards Lifesciences	2	$74
Stryker	2	$54
Inari Medical, Inc.	1	$29
Cleerly, Inc.	1	$28
Novo Nordisk	1	$22
Johnson & Johnson	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PERCLOSE PROGLIDE$1,529
CARDIOMEMS$580
RotarexS 6 F x 135 cm$470
HawkOne$361
Repatha$348
ENSITE$328
Impella$248
ONYX FRONTIER$238
COREVALVE EVOLUT R$226
EnSite Precision Cardiac Mapping System$208
GlideWire$192
ENSITE PRECISION$165
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$154
FABRAZYME$150
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$140
Penumbra System$134
IN.PACT Admiral$133
AngioVac$131
CAMZYOS$125
ELIQUIS$124

How this compares

$10,296 in reported general payments places this provider in the 45th percentile of 686 interventional cardiology providers in Texas.

See all interventional cardiology providers in Texas →

Medicare billing

Part B allowed, 2024

$110,698

Medicare patients

740

Services billed

1,631

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	25	$24,492
BrilintaTicagrelor	15	$8,688
Ranolazine ErRanolazine	33	$3,165
Rosuvastatin Calcium	33	$831
Metoprolol Succinate	46	$718
Isosorbide Mononitrate ErIsosorbide Mononitrate	51	$568
Bumetanide	16	$519
ClopidogrelClopidogrel Bisulfate	24	$360
Losartan Potassium	39	$305
Spironolactone	15	$212
Atorvastatin Calcium	26	$209
Carvedilol	25	$154
Nitroglycerin	18	$133
Furosemide	27	$131
Amlodipine Besylate	28	$125

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Abilene

Robert StolerDallas$8.2M
James ChoiDallas$5.2M
Srinivasa PotluriPlano$5.1M
Neal KleimanHouston$4.8M
Juan GranadaHouston$4.3M
Ira LieberKingwood$3.3M
Cara Ann EastDallas$3M
Abhijeet DhobleHouston$2.7M
Jeffrey CarrTyler$2.7M
M Asad KarimMcKinney$2.7M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →